v3 Template
B

Brandon Capital

Life Sciences / Healthcare ~840 employees
Founded
--
Employees (Est.)
~840
42 leaders known
Total Funding
$619.0M
Funding Rounds
2
Last Funding
2025-07-24

About Brandon Capital

Brandon Capital Partners is a venture capital firm focused on developing the next generation of medical innovations in the life sciences sector. They provide support from early-stage seed investment to expansion capital, aiding companies from proof-of-concept to commercialization, with a mission to achieve groundbreaking medical innovation, better patient outcomes, and strong financial returns.

Products & Services

Perx:A digitally-scaled care management program using daily motivation for managing chronic conditions.
TamoRx:Developing novel immuno-oncology small molecule inhibitors.
Pheon Therapeutics:Developing first-in-class ADCs to treat cancer.
NRG Therapeutics:Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders.
Entact Bio:Developing a new class of therapeutics to enhance the function of beneficial proteins.
CatalYm:Reversing GDF-15-mediated immunosuppression to induce anti-tumor responses.
AstronauTx:Targeting neurodegenerative diseases by improving disrupted physiological processes leading to dementia.
Myricx Bio:Developing novel payloads for antibody drug conjugates (ADCs) based on N-myristoyltransferase inhibitors for cancer treatment.

Specialties

Early-stage seed investment Expansion capital Life science venture investing Medical innovation commercialization Immuno-oncology Neurodegenerative therapeutics Antibody Drug Conjugates (ADCs) Chronic condition management

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Fund Close
T: -
FT: Fund Close
A: 439000000
MR: -
FA: A$439 million
FAN: 439000000
D: 2025-07-24
FD: 2025-07-24
6 investors
2 RT: Venture Capital Fund
T: -
FT: Venture Capital Fund
A: 180000000
MR: -
FA: A$270 million (US$180 million)
FAN: 180000000
D: 2024-06-04
FD: 2024-06-04
3 investors
Fund Close Latest
2025-07-24
$439.0M
6 investors (Pro only)
Venture Capital Fund 2024-06-04
$180.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Chris Nave

Founding Partner & Managing Director

S

Stephen Thompson

Founding Partner & Managing Director

M

Melissa McBurnie

Partner & Head of Impact

C

Christopher Smith

Partner

J

Jonathan Tobin

Partner

K

Katherine Jackman

Investment Manager

View 39 more team members with Pro

Unlock Full Team Directory

Recent News

Brandon Capital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Healthcare
Company Size
~840 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro